GlassScriptPhysician profile
Stephanie D Flagg
NPI 1780682815
$11,240.12
in general payments reported to CMS, 2019-2025
46 companies · $2,194 in 2025
The $2,194 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,489 · 2020: $846 · 2021: $1,180 · 2022: $1,551 · 2023: $1,854 · 2024: $2,126 · 2025: $2,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,061 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,061.26 |
| Education | $113.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,849.03 | 2019-2025 | Tavneos, Enbrel, Evenity |
| Abbvie INC. | $1,562.25 | 2019-2025 | |
| Ucb, INC. | $862.60 | 2019-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $710.21 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $680.92 | 2021-2025 | Saphnelo |
| Janssen Biotech, INC. | $625.29 | 2019-2024 | Tremfya, Simponi Aria, Remicade |
| Genentech USA, INC. | $527.09 | 2019-2025 | Actemra, Rituxan |
| Pfizer INC. | $507.97 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $375.63 | 2022-2025 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.92 | 2019-2024 | Cyltezo, Spevigo |
| Lilly USA, LLC | $309.51 | 2019-2025 | Taltz |
| Fresenius Kabi USA, LLC | $263.70 | 2023-2025 | Idacio, Tyenne |
| Radius Health, INC. | $238.75 | 2019-2024 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $227.28 | 2019-2025 | Orencia |
| Alexion Pharmaceuticals, INC. | $202.34 | 2019-2024 | Strensiq |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Flagg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.